11-118436670-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001197104.2(KMT2A):​c.158C>T​(p.Ala53Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00176 in 1,220,738 control chromosomes in the GnomAD database, including 106 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A53A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0065 ( 54 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 52 hom. )

Consequence

KMT2A
NM_001197104.2 missense

Scores

2
2
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.0170

Publications

12 publications found
Variant links:
Genes affected
KMT2A (HGNC:7132): (lysine methyltransferase 2A) This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
KMT2A Gene-Disease associations (from GenCC):
  • Wiedemann-Steiner syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Illumina, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0011565089).
BP6
Variant 11-118436670-C-T is Benign according to our data. Variant chr11-118436670-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 252562.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0522 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2ANM_001197104.2 linkc.158C>T p.Ala53Val missense_variant Exon 1 of 36 ENST00000534358.8 NP_001184033.1 Q03164-3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2AENST00000534358.8 linkc.158C>T p.Ala53Val missense_variant Exon 1 of 36 1 NM_001197104.2 ENSP00000436786.2 Q03164-3
ENSG00000285827ENST00000648261.1 linkc.-798-32105C>T intron_variant Intron 1 of 6 ENSP00000498126.1 A0A3B3ITZ1

Frequencies

GnomAD3 genomes
AF:
0.00647
AC:
965
AN:
149140
Hom.:
51
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00149
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0551
Gnomad ASJ
AF:
0.000290
Gnomad EAS
AF:
0.00295
Gnomad SAS
AF:
0.000209
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000552
Gnomad OTH
AF:
0.00684
GnomAD2 exomes
AF:
0.00256
AC:
17
AN:
6630
AF XY:
0.00241
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.462
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000683
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.0161
GnomAD4 exome
AF:
0.00111
AC:
1184
AN:
1071488
Hom.:
52
Cov.:
29
AF XY:
0.00106
AC XY:
540
AN XY:
509898
show subpopulations
African (AFR)
AF:
0.000503
AC:
11
AN:
21852
American (AMR)
AF:
0.0929
AC:
711
AN:
7652
Ashkenazi Jewish (ASJ)
AF:
0.00145
AC:
19
AN:
13092
East Asian (EAS)
AF:
0.00367
AC:
91
AN:
24798
South Asian (SAS)
AF:
0.000151
AC:
3
AN:
19806
European-Finnish (FIN)
AF:
0.00117
AC:
33
AN:
28150
Middle Eastern (MID)
AF:
0.000337
AC:
1
AN:
2968
European-Non Finnish (NFE)
AF:
0.000207
AC:
189
AN:
911104
Other (OTH)
AF:
0.00300
AC:
126
AN:
42066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.587
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00650
AC:
970
AN:
149250
Hom.:
54
Cov.:
32
AF XY:
0.00697
AC XY:
508
AN XY:
72844
show subpopulations
African (AFR)
AF:
0.00148
AC:
61
AN:
41100
American (AMR)
AF:
0.0553
AC:
832
AN:
15042
Ashkenazi Jewish (ASJ)
AF:
0.000290
AC:
1
AN:
3444
East Asian (EAS)
AF:
0.00296
AC:
15
AN:
5072
South Asian (SAS)
AF:
0.000209
AC:
1
AN:
4792
European-Finnish (FIN)
AF:
0.000942
AC:
9
AN:
9554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000552
AC:
37
AN:
66986
Other (OTH)
AF:
0.00676
AC:
14
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
48
96
144
192
240
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00466
Hom.:
4
Bravo
AF:
0.0122
ExAC
AF:
0.00328
AC:
55

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Jul 31, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 24, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 04, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
21
DANN
Uncertain
0.98
DEOGEN2
Benign
0.12
.;T;.;.
Eigen
Benign
-0.21
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.54
D
LIST_S2
Benign
0.59
T;T;T;T
MetaRNN
Benign
0.0012
T;T;T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
0.34
N;N;.;N
PhyloP100
-0.017
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.37
N;N;N;.
REVEL
Benign
0.20
Sift
Pathogenic
0.0
D;D;D;.
Sift4G
Uncertain
0.030
D;D;D;.
Polyphen
0.89, 0.96
.;P;D;.
Vest4
0.074
MVP
0.58
MPC
0.80
ClinPred
0.093
T
GERP RS
1.3
PromoterAI
-0.035
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.3
Varity_R
0.14
gMVP
0.35
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9332747; hg19: chr11-118307385; COSMIC: COSV100630341; API